Last $54.46 USD
Change Today +0.46 / 0.85%
Volume 3.2M
TEVA On Other Exchanges
Symbol
Exchange
New York
Tel Aviv
OTC US
Mexico
Frankfurt
As of 8:04 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

J. Kevin Buchi BE, MBA, CPA

Chief Executive Officer, President and Director, TetraLogic Pharmaceuticals Corporation
AgeTotal Calculated CompensationThis person is connected to 76 board members in 8 different organizations across 14 different industries.

See Board Relationships
58$5,215,724
As of Fiscal Year 2013

Background*

Mr. J. Kevin Buchi, BE, MBA, CPA, has been Chief Executive Officer and President of TetraLogic Pharmaceuticals, Inc. since August 19, 2013. Most recently, Mr. Buchi served as Corporate Vice President of Global Branded Products at Teva Pharmaceutical Industries Limited from 2011 to May 2012. He served as Chief Executive Officer of Cephalon Inc. from December 23, 2010 to October 2011. He served as the Chief Operating Officer of Cephalon Inc. from January 28, 2010 to December ...

Read Full Background

Corporate Headquarters*

5 Basel Street
Petach Tikva, -- 49131

Israel

Phone: 972 3 926 7267
Fax: 972 3 923 4050

Board Members Memberships*

Director
2002-N/A
Former Director, Chairman of Audit Committee and Member of Compensation Committee
2004-2008
Former Director and Member of Audit Committee
2006-N/A
Former Director
2009-Present
Director
2010-Present
Chief Executive Officer and Director
2010-2012
Former Non-Executive Director and Member of Audit & Risk Committee
2011-Present
Director
2012-Present
Independent Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
2013-Present
Chief Executive Officer, President and Director
2013-Present
Director and Member of Compensation Committee
2013-Present
Director

Education*

BA 1976
Cornell University
MBA 1980
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Salary$175,647
Total Annual Compensation$175,647

Stock Options*

All Other Compensation$344
Exercisable Options255,597
Exercisable Options Value$792,657
Unexercisable Options766,792
Unexercisable Options Value$2,377,982
Total Value of Options$3,170,639
Total Number of Options1,022,389

Total Compensation*

Total Annual Cash Compensation$175,991
Total Short Term Compensation$175,647
Other Long Term Compensation$344
Total Calculated Compensation$5,215,724
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVA:US $54.46 USD +0.46

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.